A controlled trial of CPAP therapy on metabolic control in individuals with impaired glucose tolerance and sleep apnea
However, it has shown remarkable success in treating emotional eating and supporting weight loss
Drug exposure The study cohort consisted of new users of GLP-1RAs (dulaglutide, exenatide, liraglutide, lixisenatide or semaglutide), SGLT2 inhibitors (canagliflozin, dapagliflozin or empagliflozin), metformin and other second- or third-line glucose-lowering drugs (thiazolidinediones, dipeptidyl peptidase-4 inhibitors, sulfonylureas, meglitinides, -glucosidase inhibitors, insulin or a combination of glucose-lowering drugs)
This allows your provider to personalize your semaglutide dose and consider combination therapies like GLP-Squared if warranted
Side-Effect Management Nausea, constipation, reflux, fatigue, and low appetite can all interfere with maintenance
Wegovy y Saxenda tambin estn aprobados para adolescentes de 12 aos o ms con obesidad